Nanotechnology for immuno-oncology | Nature Cancer

Antonia, S. J. et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N. Engl. J. Med. 377, 1919–1929 (2017).

CAS 
PubMed 

Google Scholar 

Pires da Silva, I. et al….